X BODY Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 16

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $155M

X BODY General Information

Description

Developer of human monoclonal antibody therapeutics. The company develops technologies that produce stable and functional binding molecules enabling the discovery of human antibodies against therapeutic target.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Corporate Office
  • 100 Beaver Street
  • Suite 101
  • Waltham, MA 02453
  • United States
+1 (781) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

X BODY Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 01-Jun-2015 $155M 00.00 00000 Completed Generating Revenue
4. Early Stage VC 08-Apr-2015 00.000 00.00 Completed Generating Revenue
3. Early Stage VC (Series A) 23-Jan-2012 00.000 00.000 00.000 Completed Startup
2. Grant 01-Nov-2010 $500K $1M Completed Startup
1. Early Stage VC (Series A) 29-Dec-2008 $1M $1M 000 Completed Startup
To view X BODY’s complete valuation and funding history, request access »

X BODY Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 0,000 00.000000 000 00000.00 00000.00 00 00000.00 00.000
To view X BODY’s complete cap table history, request access »

X BODY Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of human monoclonal antibody therapeutics. The company develops technologies that produce stable and functiona
Biotechnology
Waltham, MA
16 As of 2015
00.00
00000 0000-00-00
000000&0 00.00

000000

et, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et d
0000000000000
Pampisford, United Kingdom
00 As of 0000
000.00
00000 0000-00-00
00000000000 000.00

000000

ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incidi
0000000000000
Milpitas, CA
00 As of 0000
00000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

X BODY Competitors (41)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
PhoreMost Venture Capital-Backed Pampisford, United Kingdom 00 000.00 00000000000 000.00
BioVision Formerly VC-backed Milpitas, CA 00 000000&0
Compass Therapeutics Formerly VC-backed Boston, MA 00 00000 000000000 00000
CytomX Therapeutics Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
Abcam Corporate Backed or Acquired Cambridge, United Kingdom 0000 00000 000000&0 00000
You’re viewing 5 of 41 competitors. Get the full list »

X BODY Executive Team (3)

Name Title Board Seat Contact Info
Gordon Binder Co-Founder & Board Member
You’re viewing 1 of 3 executive team members. Get the full list »

X BODY Board Members (3)

Name Representing Role Since
Gordon Binder Self Co-Founder & Board Member 000 0000
You’re viewing 1 of 3 board members. Get the full list »

X BODY Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

X BODY Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
United States Department of the Treasury Government 000 0000 000000 0
To view X BODY’s complete investors history, request access »

X BODY FAQs

  • When was X BODY founded?

    X BODY was founded in 2008.

  • Who is the founder of X BODY?

    Brant Binder, Richard Wagner Ph.D, and Gordon Binder are the founders of X BODY.

  • Where is X BODY headquartered?

    X BODY is headquartered in Waltham, MA.

  • What is the size of X BODY?

    X BODY has 16 total employees.

  • What industry is X BODY in?

    X BODY’s primary industry is Biotechnology.

  • Is X BODY a private or public company?

    X BODY is a Private company.

  • What is the current valuation of X BODY?

    The current valuation of X BODY is 00000.

  • What is X BODY’s current revenue?

    The current revenue for X BODY is 00000.

  • How much funding has X BODY raised over time?

    X BODY has raised $6.8M.

  • Who are X BODY’s investors?

    United States Department of the Treasury has invested in X BODY.

  • Who are X BODY’s competitors?

    PhoreMost, BioVision, Compass Therapeutics, CytomX Therapeutics, and Abcam are some of the 41 competitors of X BODY.

  • When was X BODY acquired?

    X BODY was acquired on 01-Jun-2015.

  • Who acquired X BODY?

    X BODY was acquired by Juno Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »